BIO-RAD LABORATORIES, INC. (BIO)

BIO-RAD LABORATORIES, INC. (BIO) public financial performance, SEC filing summary, and valuation metrics.

Financial highlights

Contract Revenue: 229800000 usd (2026-03-31)
Net Income: -527100000 usd (2026-03-31)
Operating Income: 34100000 usd (2026-03-31)
Gross Profit: 309400000 usd (2026-03-31)
Net Income: 759900000 usd (2025-12-31)
Gross Profit: 1339900000 usd (2025-12-31)
Operating Income: 47200000 usd (2025-12-31)
Contract Revenue: 1022700000 usd (2025-12-31)
Gross Profit: 345300000 usd (2025-06-30)
Net Income: 317800000 usd (2025-06-30)
Operating Income: 77100000 usd (2025-06-30)
Contract Revenue: 266900000 usd (2025-06-30)
Contract Revenue: 1041500000 usd (2024-12-31)
Gross Profit: 1378900000 usd (2024-12-31)
Net Income: -1844200000 usd (2024-12-31)
Operating Income: 269000000 usd (2024-12-31)
Contract Revenue: 276200000 usd (2024-09-30)
Operating Income: 64466000 usd (2024-09-30)
Gross Profit: 355903000 usd (2024-09-30)
Net Income: 653172000 usd (2024-09-30)